Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Vokinger, Kerstin Noelle, Hediger, Simon, Casolino, Raffaella, Trapani, Dario and de Vries, Elisabeth G.E. (2026) Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study. Lancet Oncology, (doi: 10.1016/S1470-2045(26)00432-8) (PMID:42790449) Text 396580.pdf - Published Version Available under License Creative Commons Attribution.
Casolino, R. et al. (2026) Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncology, 27(10), e454-e507. (doi: 10.1016/S1470-2045(26)00302-5) (PMID:42790448) Full text not currently available from Enlighten. Abstract Cancer genomics and precision oncology are increasingly central to cancer care, but many health systems struggle to implement them equitably, effectively, and sustainably.
Study recruitment centres The Predicting Response to Immunotherapy for Melanoma with Gut Microbiome and Metabolomics (PRIMM) study comprises two prospective observational cohort studies recruiting patients in parallel in the United Kingdom (PRIMM-UK) and the Netherlands (PRIMM-NL).
25 References 1796 Citing Articles Letters Related Articles Abstract Background Everolimus, an oral inhibitor of mammalian target of rapamycin (mTOR), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. We evaluated the agent in a prospective, randomized, phase 3 study.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
